How to best manage concomitant procedures in structural heart therapies?

Sponsored by Abbott

Chairpersons: F. Maisano, D. Tchétché

Learning Objectives

  • To learn the preferred strategy for bi-valvular disease: while a staged approach may represent a preferable strategy in selected patients, concomitant treatment of combined cardiac diseases represents an appealing option in a majority of patients
  • To learn more about the Portico valve specifically designed for future patient care to improve TAVI procedures outcome